Stay updated with breaking news from Bio Techne. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
StockNews.com lowered shares of Bio-Techne (NASDAQ:TECH – Free Report) from a buy rating to a hold rating in a report published on Saturday. Several other brokerages also recently issued reports on TECH. Stephens reaffirmed an overweight rating and set a $100.00 price target on shares of Bio-Techne in a report on Wednesday, August 9th. TheStreet […]
Bio-Techne (NASDAQ:TECH – Free Report) had its target price cut by KeyCorp from $115.00 to $80.00 in a research note released on Wednesday, Benzinga reports. They currently have an overweight rating on the biotechnology company’s stock. KeyCorp also issued estimates for Bio-Techne’s Q3 2024 earnings at $0.43 EPS and Q4 2024 earnings at $0.47 EPS. […]
Bio-Techne (NASDAQ:TECH – Get Free Report) had its price objective dropped by investment analysts at Stifel Nicolaus from $104.00 to $65.00 in a research report issued on Thursday, Benzinga reports. The firm presently has a “buy” rating on the biotechnology company’s stock. Stifel Nicolaus’ price target suggests a potential upside of 17.31% from the stock’s […]
Bio-Techne Co. (NASDAQ:TECH – Free Report) – Equities researchers at Leerink Partnrs lowered their Q3 2024 EPS estimates for Bio-Techne in a research note issued to investors on Tuesday, October 31st. Leerink Partnrs analyst P. Souda now forecasts that the biotechnology company will earn $0.40 per share for the quarter, down from their prior estimate […]
Bio-Techne Co. (NASDAQ:TECH – Free Report) – Investment analysts at KeyCorp increased their Q3 2024 EPS estimates for Bio-Techne in a research note issued to investors on Tuesday, October 31st. KeyCorp analyst P. Knight now expects that the biotechnology company will post earnings per share of $0.43 for the quarter, up from their previous estimate […]